Locally Advanced Pancreatic Cancer research hub
4 indexed studies · 2 currently recruiting
- active not recruitingPHASE2
FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma
This study looks at a new treatment called OncoSil™ alongside standard chemotherapy (FOLFIRINOX) for locally advanced pancreatic cancer. Researchers want to see if adding OncoSil™ is safe and effective for people who haven't had previous treatment for their pancreatic cancer.
Australia · Belgium · Italy - not yet recruitingPHASE1
Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer
This early-stage study is looking at a new, personalised vaccine treatment for advanced bowel or pancreatic cancer. It checks if the treatment is safe, possible to give, and if it helps control the cancer. Researchers are also figuring out the right dose.
France - recruitingNA
Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer
This study looks at a new treatment called Irreversible Electroporation (IRE), also known as NanoKnife, for people with pancreatic cancer that has spread locally but not to distant parts of the body. It combines IRE with chemotherapy to see if it improves how long people live and keeps the cancer from growing.
Canada - authorisedTherapeutic exploratory (Phase II)
A Phase 2, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of Ampligen® Compared to Control Group / No Treatment Following FOLFIRINOX in Subjects with Locally Advanced Pancreatic Adenocarcinoma
This study is looking at a new medicine called Ampligen for people with pancreatic cancer that has spread nearby but not to other parts of the body. It aims to see if Ampligen can stop the cancer from growing for longer. It's in an early stage of testing.
Netherlands